Skip to main content
Top
Published in: Clinical Rheumatology 7/2008

01-07-2008 | Original Article

High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease

Authors: Arturo Borzutzky, Miguel Gutiérrez, Eduardo Talesnik, Iván Godoy, Jonathan Kraus, Rodrigo Hoyos, Pilar Arnaiz, Mónica Acevedo

Published in: Clinical Rheumatology | Issue 7/2008

Login to get access

Abstract

Kawasaki disease (KD) produces endothelial inflammation, which may lead to dilatation and aneurysms of coronary and peripheral arteries. Previous studies have suggested that these patients can present endothelial dysfunction that can predispose to coronary vascular events late after KD. The purpose of this study was to determine the cardiovascular risk profile and endothelial function of Chilean children with history of KD. In a prospective case-control study, 11 patients with history of KD (age 10.6 ± 2.0 years, interval from initial episode 8.1 ± 3.6 years) and 11 healthy, age-, gender-, and BMI z score-matched controls were evaluated with blood pressure (BP), a fasting lipid profile, high sensitivity C-reactive protein (hsCRP), and flow-mediated dilatation of the brachial artery (FMD). One KD patient (9.1%) had persistent coronary aneurysms. There was a significant difference of mean and log-transformed concentrations of hsCRP between case and control groups (2.3 ± 3.0 vs 0.5 ± 0.3 mg/l, P = 0.045). None of the patients with elevated hsCRP had persistent coronary arterial lesions. No difference was found in systolic BP z score between the case and control groups. Diastolic BP z score was significantly higher in cases than controls (P = 0.039). There were no significant differences of FMD between cases and controls. Mean fasting total cholesterol, high-density and low-density lipoprotein, and triglycerides in cases were normal, with no significant difference vs controls. This study shows that Chilean children with history of KD have increased levels of hsCRP, possibly reflecting persistent low-grade inflammation. The prognostic value of hsCRP in KD patients deserves further investigation.
Literature
1.
go back to reference Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRef Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRef
2.
go back to reference Kato H, Sugimura T, Akagi T et al (1996) Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMed Kato H, Sugimura T, Akagi T et al (1996) Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMed
3.
go back to reference Deng YB, Li TL, Xiang HJ et al (2003) Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 22:34–39PubMedCrossRef Deng YB, Li TL, Xiang HJ et al (2003) Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 22:34–39PubMedCrossRef
4.
go back to reference Dhillon R, Clarkson P, Donald AE et al (1996) Endothelial dysfunction late after Kawasaki disease. Circulation 94:2103–2106PubMed Dhillon R, Clarkson P, Donald AE et al (1996) Endothelial dysfunction late after Kawasaki disease. Circulation 94:2103–2106PubMed
5.
go back to reference Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 16:178PubMed Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 16:178PubMed
6.
go back to reference Ikemoto Y, Ogino H, Teraguchi M et al (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26:782–786PubMedCrossRef Ikemoto Y, Ogino H, Teraguchi M et al (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26:782–786PubMedCrossRef
7.
go back to reference Silva AA, Maeno Y, Hashmi A et al (2001) Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr 138:400–405PubMedCrossRef Silva AA, Maeno Y, Hashmi A et al (2001) Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr 138:400–405PubMedCrossRef
8.
go back to reference Kadono T, Sugiyama H, Hoshiai M et al (2005) Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol 26:385–390PubMedCrossRef Kadono T, Sugiyama H, Hoshiai M et al (2005) Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol 26:385–390PubMedCrossRef
9.
go back to reference Noto N, Okada T, Yamasuge M et al (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107:1095–1099PubMedCrossRef Noto N, Okada T, Yamasuge M et al (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107:1095–1099PubMedCrossRef
10.
go back to reference Cheung YF, Ho MH, Tam SC et al (2004) Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90:1281–1285PubMedCrossRef Cheung YF, Ho MH, Tam SC et al (2004) Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90:1281–1285PubMedCrossRef
11.
go back to reference Ooyanagi R, Fuse S, Tomita H et al (2004) Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int 46:398–402PubMedCrossRef Ooyanagi R, Fuse S, Tomita H et al (2004) Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int 46:398–402PubMedCrossRef
12.
go back to reference Newburger JW, Burns JC, Beiser AS et al (1991) Altered lipid profile after Kawasaki syndrome. Circulation 84:625–631PubMed Newburger JW, Burns JC, Beiser AS et al (1991) Altered lipid profile after Kawasaki syndrome. Circulation 84:625–631PubMed
13.
go back to reference Mitani Y, Sawada H, Hayakawa H et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38–43PubMedCrossRef Mitani Y, Sawada H, Hayakawa H et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38–43PubMedCrossRef
14.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
15.
go back to reference Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef
16.
go back to reference National Cholesterol Education Program (1992) Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(Suppl):525–584 National Cholesterol Education Program (1992) Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(Suppl):525–584
17.
go back to reference Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511PubMedCrossRef Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511PubMedCrossRef
18.
go back to reference Ford ES, Ajani UA, Mokdad AH et al (2005) The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878–881PubMedCrossRef Ford ES, Ajani UA, Mokdad AH et al (2005) The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878–881PubMedCrossRef
19.
go back to reference Acevedo M, Arnaiz P, Barja S et al (2007) Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children. Rev Esp Cardiol 60:1051–1058PubMedCrossRef Acevedo M, Arnaiz P, Barja S et al (2007) Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children. Rev Esp Cardiol 60:1051–1058PubMedCrossRef
20.
go back to reference Ford ES, Giles WH, Myers GL et al (2003) C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999–2000. Clin Chem 49:1353–1357PubMedCrossRef Ford ES, Giles WH, Myers GL et al (2003) C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999–2000. Clin Chem 49:1353–1357PubMedCrossRef
21.
go back to reference Albert MA, Ridker PM (2006) C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 114: e67–e74PubMedCrossRef Albert MA, Ridker PM (2006) C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 114: e67–e74PubMedCrossRef
22.
go back to reference Ridker PM, Wilson PW, Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818–2825PubMedCrossRef Ridker PM, Wilson PW, Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818–2825PubMedCrossRef
23.
go back to reference Furuyama H, Odagawa Y, Katoh C et al (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRef Furuyama H, Odagawa Y, Katoh C et al (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRef
24.
go back to reference Kavey RE, Allada V, Daniels SR et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114:2710–2738PubMedCrossRef Kavey RE, Allada V, Daniels SR et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114:2710–2738PubMedCrossRef
25.
go back to reference Graham TP Jr, Driscoll DJ, Gersony WM et al (2005) 36th Bethesda Conference: recommendations for competitive athletes with cardiovascular disease: Task Force 2. J Am Coll Cardiol 45:1326–1333PubMedCrossRef Graham TP Jr, Driscoll DJ, Gersony WM et al (2005) 36th Bethesda Conference: recommendations for competitive athletes with cardiovascular disease: Task Force 2. J Am Coll Cardiol 45:1326–1333PubMedCrossRef
Metadata
Title
High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease
Authors
Arturo Borzutzky
Miguel Gutiérrez
Eduardo Talesnik
Iván Godoy
Jonathan Kraus
Rodrigo Hoyos
Pilar Arnaiz
Mónica Acevedo
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0808-6

Other articles of this Issue 7/2008

Clinical Rheumatology 7/2008 Go to the issue